BalitCRLynchCNIsbisterGK.Bupropion poisoning: a case series. Med J Aust. 2003;178:61-63.
2.
KaraHAkABayirAAcarDIstanbulluoğluRDeğirmenciS.Seizures after overdoses of bupropion intake. Balkan Med J. 2013;30:248-249. doi:10.5152/balkanmedj.2012.094.
3.
BooraKCummingsMRMarshallDR.Generalized seizure in three adolescents with bupropion overdose. J Child Adolesc Psychopharmacol. 2010;20:159-160. doi:10.1089/cap.2009.0016.
4.
MorazinFLumbrosoAHarryPet al. Cardiogenic shock and status epilepticus after massive bupropion overdose. Clin Toxicol (Phila). 2007;45:794-797. doi:10.1080/15563650701665076.
5.
StarrPKlein-SchwartzWSpillerHKernPEkleberrySEKunkelS.Incidence and onset of delayed seizures after overdoses of extended-release bupropion. Am J Emerg Med. 2009;27:911-915. doi:10.1016/j.ajem.2008.07.004.
6.
SpillerHASchaefferSE.Multiple seizures after bupropion overdose in a small child. Pediatr Emerg Care. 2008;24:474-475. doi:10.1097/PEC.0b013e31817de2e6.
7.
GentonPGélisseP.Antimyoclonic effect of levetiracetam. Epileptic Disord. 2000;2:209-212.
8.
KraussGLBerginAKramerREChoYWReichSG.Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam. Neurology. 2001;56:411-412.
9.
SettleECStahlSMBateySRJohnstonJAAscherJA.Safety profile of sustained-release bupropion in depression: results of three clinical trials. Clin Ther. 1999;21:454-463.
10.
FoleyKFDeSantyKPKastRE.Bupropion: pharmacology and therapeutic applications. Expert Rev Neurother. 2006;6:1249-1265. doi:10.1586/14737175.6.9.1249.
11.
PreskornSH.Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine. J Clin Psychiatry. 1995;56(suppl 6):12-21.
MendonçaCRochaSMeirelesJPestanaPTeixeiraCAragãoI.Sustained-release bupropion overdose: a case report. Int J Med Pharm Case Reports. 2015;3:38-43. doi:10.9734/IJMPCR/2015/14703.
14.
StrianoPManganelliFBoccellaPPerrettiAStrianoS.Levetiracetam in patients with cortical myoclonus: a clinical and electrophysiological study. Mov Disord. 2005;20:1610-1614. doi:10.1002/mds.20530.
15.
GelissePCrespelAGentonPBaldy-MoulinierM.Dramatic effect of levetiracetam on epileptic negative myoclonus. Acta Neurol Scand. 2003;107:302-303.
16.
BudhramALipsonDNesathuraiSHarveyDRathboneMP.Postanoxic myoclonus: two case presentations and review of medical management. Arch Phys Med Rehabil. 2014;95:588-590. doi:10.1016/j.apmr.2013.09.008.
17.
FruchtSJLouisEDChuangCFahnS.A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus. Neurology. 2001;57:1112-1114.
18.
LimLLAhmedA.Limited efficacy of levetiracetam on myoclonus of different etiologies. Parkinsonism Relat Disord. 2005;11:135-137. doi:10.1016/j.parkreldis.2004.07.010.
